Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KenvueKVUE -1.28%70 Buyback Yield % is 0.36 as of Jul. 14, 2026, which is 9% above its 10-year median of 0.33. GuruFocus rates KVUE with a GF Score™ of 70/100 and a GF Value™ of $20.40 (Fairly Valued). The stock has 6 warning signs investors should review. Among 558 Consumer Packaged Goods companies, Kenvue ranks better than 66.67% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Kenvue's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Kenvue's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kenvue Buyback Yield % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Kenvue's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Kenvue's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kenvue (KVUE) has a Buyback Yield % of 0.36 as of Jul. 14, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Kenvue and its competitors. This is near median its historical median of 0.33. According to the industry distribution chart, Kenvue ranks #186 out of 558 companies in the Consumer Packaged Goods industry, placing it in the top 33.3%.
Is Kenvue's Buyback Yield % too high?
Kenvue's current Buyback Yield % of 0.36 is near median its 10-year median of 0.33. Based on the distribution chart, Kenvue ranks #186 out of 558 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Kenvue has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Kenvue's Buyback Yield % compare to KMB and EL?
According to the Consumer Packaged Goods industry distribution chart, Kenvue ranks #186 out of 558 companies for Buyback Yield %. This puts Kenvue in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Consumer Packaged Goods company?
A good Buyback Yield % depends on the Consumer Packaged Goods industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Kenvue and its competitors. Kenvue's current Buyback Yield % is 0.36, which is near median its own 10-year median of 0.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kenvue stock overvalued right now?
Based on GuruFocus' analysis, Kenvue (KVUE) is currently considered Fairly Valued. The stock's GF Value™ is $20.40, compared to a current price of $19.23 — trading 5.7% below its estimated fair value. The current Buyback Yield % is 0.36, which is near median its 10-year median of 0.33. Kenvue's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Kenvue (KVUE), the current Buyback Yield % is 0.36 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kenvue (KVUE) Overvalued in 2026?
Based on GuruFocus' analysis, Kenvue stock appears to be undervalued.
The current stock price of $19.23 is trading 5.7% below its estimated GF Value™ of $20.40.
GuruFocus considers Kenvue to be Fairly Valued.
Key valuation signals for KVUE:
Buyback Yield %: 0.36 (near median its 10-year median of 0.33)
GF Value™: $20.40 vs. price of $19.23 (5.7% below fair value)
No single metric tells the full story. See the KVUE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
70GF Score
Get the complete analysis for KVUE
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KVUE has been successfully added to your 
